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Objectives This study sought to assess the impact of muscular strength on mortality in men with hypertension.
Background Muscular strength is inversely associated with mortality in healthy men, but this association has not been exam-
ined in men with hypertension.
Methods We followed 1,506 hypertensive men age 40 years and older enrolled in the Aerobics Center Longitudinal Study
from 1980 to 2003. Participants received an extensive medical examination at baseline. Muscular strength was
quantified by combining 1 repetition maximum (1-RM) measures for leg and bench press and cardiorespiratory
fitness assessed by maximum exercise test on a treadmill.
Results During an average follow-up of 18.3 years, 183 deaths occurred. Age-adjusted death rates per 10,000 person-
years across incremental thirds of muscular strength were 81.8, 65.5, and 52.0 (p  0.05 for linear trend). Mul-
tivariable Cox regression hazard ratios were 1.0 (reference), 0.81 (95% confidence interval [CI]: 0.57 to 1.14),
and 0.59 (95% CI: 0.40 to 0.86) across incremental thirds of muscular strength. After further adjustment for
cardiorespiratory fitness, those participants in the upper third of muscular strength still had a lower risk of death
(hazard ratio [HR]: 0.66; 95% CI: 0.45 to 0.98). In the muscular strength and CRF combined analysis, men si-
multaneously in the upper third of muscular strength and high fitness group had the lowest mortality risk among
all combination groups (HR: 0.49; 95% CI: 0.30 to 0.82), with men in the lower third of muscular strength and
low fitness group as reference.
Conclusions High levels of muscular strength appear to protect hypertensive men against all-cause mortality, and this is in
addition to the benefit provided by cardiorespiratory fitness. (J Am Coll Cardiol 2011;57:1831–7) © 2011 by
the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.12.025c
(
p
U
y
Hypertension is associated with an increased risk of all-
cause and cardiovascular disease (CVD) mortality (1). Re-
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10, 2010, accepted December 14, 2010.ent calculations show nearly 8 million deaths worldwide
about 13.5% of the global total) attributable to high blood
ressure (2). It remains a major public health problem in the
nited States, with 58.4 million Americans (28.7%) age 18
ears or older having hypertension (systolic blood pressure
140 mm Hg and/or diastolic blood pressure90 mm Hg)
(1). Although awareness, treatment, and control of hy-
pertension appear to be improving in recent decades (1),
this is still far from optimal, and with the ongoing obesity
epidemic, there may be an increase in most CVD,
including hypertension (3).
Cardiorespiratory fitness (CRF) provides strong and in-
dependent prognostic information about the overall risk of
illness and death across a broad spectrum of medical
conditions, including hypertension (4–6). It is generally
accepted that regular exercise can help prevent the develop-
ment of hypertension, lower blood pressure in normotensive
and hypertensive adults, and reduce mortality risk in indi-
viduals with hypertension (7,8). The independent role of
T
m
w
s
s
s
r
C
s
e
c
i
m
k
w
s
s
s
q
a
H
c
u
d
l
d
D
c
o
q
h
b
o
a
r
m
b
v
C
w
a
l
b
p
m
t
t
f
c
0
2
1832 Artero et al. JACC Vol. 57, No. 18, 2011
Hypertension, Muscular Strength, and Mortality May 3, 2011:1831–7muscular strength in the preven-
tion of chronic disease is now
increasingly being recognized
(9). Resistance-type physical ac-
tivities are major determinants of
muscular strength and are cur-
rently prescribed by prestigious
health organizations for improv-
ing health and fitness (8,10).
Findings from meta-analyses in-
dicate that resistance training
could produce a reduction of ap-
proximately 3.0 and 3.5 mm Hg for resting systolic and
diastolic blood pressure, respectively (11,12), which repre-
sents approximate decreases of 2% and 4%, respectively (12).
The blood pressure–lowering effects of resistance training
seem to be even more pronounced in individuals with
existing hypertension (13,14). Taken together, these results
suggest that moderate intensity resistance training is not
contraindicated and could become part of the nonpharma-
cological intervention strategy to prevent and combat high
blood pressure (11).
Several prospective studies have shown that muscular
strength is inversely associated with all-cause (15–22) and
cancer (22,23) mortality, but the association in persons with
hypertension has yet to be examined. Any modifiable factor
able to decrease the risk of mortality among hypertensive
individuals would be of great interest from a public health
perspective. We hypothesized that muscular strength would
have an independent protective effect on all-cause mortality
in hypertensive men.
Methods
Data for the current report are from the Aerobics Center
Longitudinal Study, a prospective study on the association
of clinical and lifestyle factors with health outcomes in
patients examined at the Cooper Clinic in Dallas, Texas,
from 1970. Between 1980 and 1989, 10,265 men underwent
muscular strength tests as part of the comprehensive med-
ical examination. Participants came to the clinic for periodic
preventive health examinations and for counseling on diet,
exercise, and other lifestyle factors associated with an increased
risk of chronic disease. Participants, thus, were volunteers, were
not paid, and were not recruited to the study as would be the
case for a clinical trial. Many were sent by their employers
for the examination, some were referred by their physicians,
and others were self-referred.
Only participants age 40 years or older and with resting
blood pressure 140/90 mm Hg or previous physician-
diagnosed hypertension were included in the present study
(n  1,668). The exclusion of younger participants was due
to the low prevalence of hypertension at those ages (1).
Among those finally selected, participants were excluded if
they reported a history of myocardial infarction, stroke, or
Abbreviations
and Acronyms
CI  confidence interval
CRF  cardiorespiratory
fitness
CVD  cardiovascular
disease
HR  hazard ratio
1-RM  1 repetition
maximumcancer (n  81); failed to achieve at least 85% of age- epredicted maximum heart rate during the treadmill test
(n  77); or died during the first year of follow-up (n  4).
hese criteria resulted in 1,506 men, all of them with a body
ass index 18.5 kg/m2. Participants were predominantly
hite and well educated and belonged to middle and upper
ocioeconomic strata. All participants gave informed con-
ent to participate in the clinical examination and follow-up
tudy. The Cooper Institute Institutional Review Board
eviewed and approved the study protocol annually.
linical examination. The clinical examination and mea-
ures of muscular strength and CRF are described in detail
lsewhere (24,25). Briefly, the baseline examination was
ompleted after an overnight fast of at least 12 h and
ncluded a physical examination and an array of clinical
easurements. Body mass index was computed as weight in
ilograms divided by height in meters squared, measured
ith a standard clinical scale and stadiometer. Resting
ystolic and diastolic blood pressure was measured in the
eated position as the first and fifth Korotkof sounds, using
tandard auscultation methods after at least 5 min of sitting
uietly (26). Two or more readings separated by 2 min were
veraged. If the first 2 readings differed by more than 5 mm
g, additional readings were obtained and averaged. Con-
entrations of total cholesterol and glucose were measured
sing automated techniques in accordance with the stan-
ards of the Centers for Disease Control and Prevention
ipid standardization program. Hypercholesterolemia was
efined as a total cholesterol concentration of 240 mg/dl.
iabetes mellitus was defined as a fasting plasma glucose
oncentration of 126 mg/dl, previous physician diagnosis
f diabetes, or use of insulin. Participants completed a
uestionnaire on medical history that included a personal
istory of myocardial infarction, stroke, hypertension, dia-
etes, and cancer; a family history of CVD; a family history
f cancer; smoking status; alcohol intake; and physical
ctivity (active or inactive). Physical inactivity was defined as
eporting no physical activity during leisure time in the 3
onths before the examination.
We assessed muscular strength in the upper and lower
ody using a standardized strength testing protocol and
ariable resistance weight machines (Universal Equipment,
edar Rapids, Iowa) (25). Upper body strength was assessed
ith a 1 repetition maximum (1-RM) supine bench press,
nd lower body strength was assessed with a 1-RM seated
eg press. Initial loads were 70% of body weight for the
ench press and 100% for the leg press. After a brief rest
eriod, we added increments of 2.27 to 4.54 kg until
aximum effort was achieved for each lift, usually after 5
rials. Participants were able to lift the initial load at least 1
ime. They were instructed on proper breathing and lifting
orm for each movement. The intraclass correlation coeffi-
ient for 1-RM bench and 1-RM leg press was 0.90 and
.83, respectively, in a subgroup of 246 men who underwent
muscular strength assessments within 1 year (25).
A muscular strength index was computed by takingach individual’s 1-RM score for the bench press and leg
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weight, and dividing the scores into 3 age groups (40 to 49
years, 50 to 59 years, and60 years). In each age group, the
individual’s scores were standardized using the formula:
standardized value (valuemean)/SD. These new scores
for the bench press and leg press were averaged to express an
age-specific standardized composite score for each individ-
ual, following our earlier studies (14,22,23). For the analy-
ses, we used thirds of this age-specific strength score.
We assessed CRF by a maximum treadmill test using a
modified Balke protocol (24,27). Participants were encour-
aged to give maximum effort, and the test was stopped when
participants reached volitional exhaustion or the doctor
intervened for medical reasons. The mean percentage of
age-predicted maximum heart rate (220  age) achieved
during exercise was 102.3  7.1, indicating that a majority
of participants achieved maximum effort. Exercise duration
using this protocol is highly correlated with measured
maximum oxygen uptake (r  0.92) (28). We estimated
maximum metabolic equivalents (1 metabolic equivalent 
3.5 ml oxygen uptake/kg/min) from the final treadmill
speed and grade (29). We dichotomized CRF as low fitness
and high fitness corresponding to the lower and the upper
50%, respectively, of the age-specific distribution of treadmill
exercise duration from this particular population.
Mortality surveillance. All participants were followed
from the date of their baseline examination until their date
of death or until December 31, 2003. We computed
man-years of exposure as the sum of follow-up time among
decedents and survivors. The National Death Index was the
primary data source for mortality surveillance, which has
been shown to be an accurate method of ascertaining deaths
in observational studies, with high sensitivity (96%) and
specificity (100%) (30).
Statistical analysis. We described baseline characteristics
of the study population by vital status and by thirds of
muscular strength. Differences between survivors and dece-
dents were tested using the Student t test and chi-square
test. Tests for linear trends across muscular strength cate-
gories were calculated using general linear models. We used
Cox proportional hazards regression to estimate hazard
ratios (HRs), 95% confidence intervals (CIs), and mortality
rates (deaths per 10,000 person-years of follow-up), accord-
ing to muscular strength categories. In multivariable analy-
ses, we adjusted for age in model 1 and for age, physical
activity (active or inactive), smoking (current smoker or
not), alcohol intake (5 drinks a week or not), body mass
index, systolic and diastolic blood pressure, total cholesterol,
presence or absence diabetes, abnormal electrocardiogram,
and family history of CVD in model 2. Additional analyses
were done after further adjustment for CRF in model 3,
entered as a continuous variable (treadmill test duration in
minutes). A total of 666 participants (44.2%) reported a
family history of CVD.
We also examined the combined effects of muscular
strength and CRF on all-cause mortality. For this analysis,we created 6 categories for combinations of strength and
CRF on the basis of thirds of muscular strength and
dichotomized these into low-fitness and high-fitness groups
for CRF. We compared the effect of each combination of
strength and fitness status with the reference group (low
fitness, low strength). Cumulative hazard plots grouped by
exposure suggested no appreciable violations of the propor-
tional hazards assumption. We calculated 2-sided p values
and considered those 0.05 as significant. Analyses were
done using SAS statistical software, version 9.2 (SAS
Institute, Cary, North Carolina).
Results
During an average follow-up of 18.3 years and 27,560
man-years of observation, 183 deaths (12.2%) occurred.
Table 1 shows the baseline characteristics of the participants
on the basis of vital status and thirds of muscular strength.
Muscular strength and exercise test duration and maximum
metabolic equivalents were significantly higher in survivors
than in decedents. A direct gradient of treadmill test
duration across thirds of muscular strength was observed.
Age, fasting blood glucose, systolic blood pressure, and
prevalence of current smokers, alcohol intake of 5 drinks
weekly, diabetes mellitus, and family history of premature
CVD were higher in decedents. Body mass index, levels of
glucose, diastolic blood pressure, and prevalence of physical
inactivity were higher in those with lower levels of muscular
strength.
Table 2 shows age-adjusted death rates and hazard ratios
(model 1) for death from all causes; hazard ratios after
further adjustment for physical activity, smoking, alcohol
intake, body mass index, systolic and diastolic blood pres-
sure, total cholesterol, diabetes, abnormal electrocardio-
gram, and family history of CVD (model 2); and after
additionally adjusting for CRF (model 3). All-cause mor-
tality rates were 1.25 (81.8/65.5) and 1.57 (81.8/52) times
greater for those in the lowest third of muscular strength
compared with those in the middle and upper thirds of
muscular strength, respectively. The age-adjusted results of
model 1 showed an inverse risk of death from all causes
across incremental thirds of muscular strength (p 0.05 for
linear trend). Those participants in the upper muscular
strength group had a 36% significantly lower risk of all-
cause mortality compared with those in the lower group.
After the additional adjustments (model 2), risks of death
remained progressively lower with higher levels of muscular
strength (p  0.05 for linear trend). Hypertensive men in
the upper muscular strength group had a 41% significantly
lower risk of all-cause mortality. Finally, after further
adjustment for CRF (model 3), the association between
muscular strength and risks of death was attenuated (p 
0.11 for linear trend), yet those participants in the upper
third of muscular strength still had a 34% lower risk of
death. Excluding deaths that occurred during the first 3
years of follow-up did not materially change these results.
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Hypertension, Muscular Strength, and Mortality May 3, 2011:1831–7Similarly, the results were virtually the same when including
those participants who did not achieve 85% of age-predicted
maximum heart rate during the treadmill test.
We additionally analyzed the association of muscular
strength and risks of all-cause mortality separately for men
younger than 60 years of age (n  1,323, 88%) and 60 years
r older (n  183, 12%), as well as for men with normal
eight (n  479, 32%) and overweight (n  1,027, 68%),
n both cases using the fully adjusted model (except age in
he analysis stratified by age, and body mass index in the
nalysis stratified by weight status). There was no interac-
ion between muscular strength and age (p  0.28) or
etween muscular strength and weight status (p  0.36) in
predicting risk of mortality. Among participants age 60
years or older, those in the upper third of muscular strength
Baseline Characteristics of Hypertensive Men in Aerobics Center LAccording to Vital Status and by Thirds of Muscular StrengthTable 1 B se ine Char cteristics of Hypertensive M in A obAccording to Vital Status and by Thirds of Muscular St
Characteristic
Vital Status
All
(n  1,506)
Survivors
(n  1,323)
Dece
(n 
Age, yrs 50.2 7.4 49.7 7.2 54.0
Body mass index, kg/m2 26.9 3.7 26.9 3.7 27.1
Treadmill time, min 17.5 4.8 17.7 4.8 15.8
Maximum metabolic equivalents† 11.4 2.4 11.5 2.4 10.6
Upper body strength
kg 66.3 15.0 66.7 14.9 63.0
kg/kg of body weight 0.8 0.2 0.8 0.2 0.7
Lower body strength
kg 132.3 26.4 132.7 26.0 129.6
kg/kg of body weight 1.5 0.3 1.6 0.3 1.5
Composite strength score 0.00 0.03 0.88 0.23
Total cholesterol, mg/dl 221.9 43.2 221.1 41.4 227.7
Fasting blood glucose, mg/dl 104.4 20.0 103.6 16.9 110.5
Blood pressure, mm Hg
Systolic 131.7 13.9 131.1 13.7 136.1
Diastolic 89.94 8.5 89.3 8.6 89.9
Physically inactive 339 (22.5) 301 (22.8) 38
Current smokers 220 (14.6) 182 (13.8) 38
Alcohol intake 5 drinks weekly 812 (53.9) 700 (52.9) 112
Baseline medical conditions
Hypercholesterolemia 450 (29.9) 389 (29.4) 61
Diabetes mellitus 93 (6.2) 69 (5.2) 24
Family history of cardiovascular disease 666 (44.2) 562 (42.3) 104
Values are mean  SD or n (%). *Comparison between survivors and decedents. †Estimated from
Rates and Hazard Ratio for All-Cause Mortality in Hypertensive MeTable 2 Rates and Hazard Ratio for All-Cause Mortality in Hype
Muscular Strength
No. of Deaths
(No. of Participants)
Age-Adjusted R
per 10,000 Perso
Lower 74 (499) 81.8
Middle 61 (508) 65.5
Upper 48 (499) 52.0
p value for linear trend
*Adjusted for age. †Adjusted for age, physical activity (active or inactive), current smoking, alcoh
diabetes, abnormal electrocardiogram, and family history of cardiovascular disease. ‡Adjusted for age, ph
index, systolic and diastolic blood pressure, total cholesterol, diabetes, abnormal electrocardiogram, famhad a 56% lower risk of death compared with those in the
lower third (HR: 0.44; 95% CI: 0.20 to 0.98).
Figure 1 shows all-cause mortality risks across combined
categories of muscular strength (thirds) and CRF (low and
high fitness). There was no significant interaction between
muscular strength and CRF in predicting risk of mortality
(p  0.46). Those participants in the low-fitness group and
upper third of muscular strength had a 48% lower risk of
mortality (HR: 0.52; 95% CI: 0.31 to 0.82) compared with
the reference group (low fitness, lower third of muscular
strength). Among participants in the high-fitness group,
men in the middle and upper thirds of muscular strength
had 39% (HR: 0.61; 95% CI: 0.37 to 0.995) and 51% (HR:
0.49; 95% CI: 0.30 to 0.82) lower risks of mortality,
respectively, compared with the reference group.
udinal Study, 1980 to 2003,enter Longitudinal Study, 1980 to 2003,
th
Muscular Strength (Thirds)
p Value*
Lower
(n  499)
Middle
(n  508)
Upper
(n  499)
p Value for
Linear Trend
0.001 50.5 7.4 50.2 74.2 49.8 7.7 0.33
0.35 28.2 4.4 26.7 3.1 25.8 3.0 0.001
0.001 15.3 4.3 17.6 4.4 19.6 4.8 0.001
0.001 10.4 2.0 11.4 2.1 12.4 2.5 0.001
.6 0.002 57.3 11.7 65.1 10.8 76.2 15.8 0.001
0.001 0.6 0.1 0.8 0.1 0.9 0.2 0.001
.0 0.15 121.4 26.1 131.9 22.5 143.6 25.7 0.001
0.008 1.3 0.2 1.5 0.1 1.8 0.2 0.001
2 0.001 0.87 0.45 0.05 0.33 0.91 0.66 0.001
.5 0.05 222.6 39.1 221.6 49.1 221.5 40.8 0.91
.7 0.001 106.8 26.4 103.0 15.4 103.5 16.2 0.005
.6 0.001 131.2 13.1 130.9 13.2 133.0 15.3 0.03
0.36 90.1 8.5 88.7 8.0 89.4 8.9 0.03
0.55 144 (28.9) 123 (24.2) 72 (14.4) 0.001
0.01 86 (17.2) 65 (12.8) 69 (13.8) 0.11
0.04 271 (54.3) 261 (51.4) 280 (56.1) 0.31
0.28 157 (35.1) 145 (28.5) 148 (29.7) 0.59
0.001 38 (7.6) 28 (5.5) 27 (5.4) 0.26
0.001 215 (43.1) 218 (42.9) 233 (46.7) 0.40
readmill speed and elevation.
Thirds of Muscular Strengthive Men by Thirds of Muscular Strength
Hazard Ratio (95% Confidence Interval)
Model 1* Model 2† Model 3‡
1.00 (reference) 1.00 (reference) 1.00 (reference)
0.80 (0.57–1.12) 0.81 (0.57–1.14) 0.86 (0.60–1.21)
0.64 (0.44–0.91) 0.59 (0.40–0.86) 0.66 (0.45–0.98)
0.048 0.02 0.11
ke (5 drinks weekly), body mass index, systolic and diastolic blood pressure, total cholesterol,ongitics C
reng
dents
183)
 7.9
 3.3
 4.7
 2.2
 15
 0.2
 29
 0.2
 0.8
 54
 34
 14
 7.6
(20.8)
(20.8)
(61.2)
(33.3)
(13.1)
(56.8)n byrtens
ate
n-Yrs
ol inta
ysical activity (active or inactive), current smoking, alcohol intake (5 drinks weekly), body mass
ily history of cardiovascular disease, and cardiorespiratory fitness (treadmill test duration in min).
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The primary finding of this study is that a high level of
muscular strength was significantly associated with a lower
risk of all-cause mortality in hypertensive men, after con-
trolling for potential confounders including CRF. The
combined analysis showed that hypertensive men with high
levels of both muscular strength and CRF presented the
lowest risk of all-cause mortality. This finding extends our
previous observation that hypertensive men with at least
moderate CRF have a lower risk of mortality (4,5,31). The
present study suggests that a high level of muscular strength
also provides an additional protective effect, and the reduc-
tion in mortality can be higher when hypertensive men have
a high level of both muscular strength and CRF.
Several prospective studies have shown that muscular
strength is inversely associated with all-cause and cancer
mortality (15-23), suggesting the important role of muscular
health in the prevention of chronic disease (9). Our study
overcomes some limitations of previous reports, such the use
of relatively small muscle groups (mainly handgrip test)
(15,16,21,32-35), short-term follow-up (4 to 6 years) (32-35),
he inclusion of only older adults (65 years and older)
32,34,35), and the absence of CRF (15,21,32-34). In our
tudy, muscular strength and CRF were moderately corre-
ated (age-adjusted partial r  0.42), suggesting that the
ssociation between muscular strength and risk of death
orks at least partially through different mechanisms than
hose associated with the protective effect of CRF. The
Figure 1 Muscular Strength, Cardiorespiratory Fitness, and Mo
Combined association of muscular strength (thirds) and cardiorespiratory fitness (
age, physical activity, current smoking, alcohol intake, body mass index, systolic a
and family history of cardiovascular disease. Error bars represent 95% confidencepparent protective effect of muscular strength against risk Af death might be due to muscular strength in itself, to
espiratory muscular strength and pulmonary function (36),
o muscle fiber type or configuration, or as a consequence of
egular physical exercise, specifically resistance exercise. We
reviously reported a strong and positive association be-
ween the frequency of self-reported resistance exercise and
aximal muscular strength in men enrolled in the Aerobics
enter Longitudinal Study (37). Results from intervention
tudies indicate that resistance training enhances muscular
trength and endurance, muscle mass, functional capacity,
aily physical activity, risk profile for CVD, and quality of
ife (10), all of which are well-known predictors of mortality
isk. The benefits of resistance training are evident in men
nd women; young adults and older individuals; normal
eight, overweight, and obese people; and people with or
ithout CVD, including hypertension (7,10).
To the best of our knowledge, this is the first study that
elates muscular strength and mortality in the high-risk
opulation of hypertensive men. Being hypertensive is
ssociated with an increased incidence of all-cause and
VD mortality (1). However, this and other studies show
hat lifestyle factors such as diet (38), regular physical
ctivity (7), CRF (4,5,31), and now muscular strength can
e effective in the management of the higher risk in
ypertensive patients. According to our results, hypertensive
en should follow the recommendations for resistance
xercise not only to reduce resting blood pressure (11,12),
ut also to reduce mortality risk. In fact, the Physical
y in Hypertension
ess, high fitness) with hazard ratio of all-cause mortality after adjustment for
stolic blood pressure, total cholesterol, diabetes, abnormal electrocardiogram,
al.rtalit
low fitn
nd dia
intervctivity Guidelines for Americans (8) encourage adults to
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Hypertension, Muscular Strength, and Mortality May 3, 2011:1831–7perform muscle-strengthening activities that involve major
muscle groups on 2 days a week, supervised by a health-
care provider in the case of people with a chronic medical
condition.
Study limitations. The results of the present study, how-
ever, should be interpreted with caution. The small number
of deaths prevents a firm conclusion and does not allow for
the examination of the relationship between muscular
strength and disease-specific mortality risk in hypertensive
men. Studies involving a larger number of deaths should
analyze the potential association between muscular strength
and CVD mortality in hypertensive people. The composi-
tion of the study sample by well-educated white men of
middle and upper socioeconomic status and the impos-
sibility of performing a parallel analysis of women need
also to be considered. However, the homogeneity of our
study group of socioeconomic factors enhances internal
validity of our findings because it reduces the likelihood
of confounding by these characteristics. In addition, men
in the Aerobics Center Longitudinal Study cohort are
very similar on key clinical measures such as lipids,
glucose, and blood pressure to participants in other large
epidemiological studies in the United States (39). We are
not aware of biological reasons to believe that the benefits
of muscular strength would be different in hypertensive
people from other ethnic or socioeconomic groups. Pro-
spective studies among diverse populations and among
women are needed.
As another potential limitation, we did not have sufficient
information on diet or medication use/adherence to include
in our analysis, which may have biased the results through
residual confounding. Hypertensive individuals on medica-
tion therapy might be more health conscious and have
healthier lifestyle habits. However, it seems unlikely that
these factors would account for all the observed association
between muscular strength and mortality. Future studies
should include such information whenever possible. In
addition, as we only have baseline data on muscular strength
and CRF, we do not know whether changes in any of these
variables occurred during follow-up and how this might
have influenced the results. It is possible that many men
with hypertension were treated at some point in the
follow-up interval, and others may have experienced in-
creases/decreases in these exposures.
Despite these limitations, a major strength of this study
was the inclusion of objective and standardized maximal
tests for muscular strength (upper and lower body) and CRF
using highly reliable measurement protocols in a relatively
large cohort of hypertensive men with extensive follow-up.
Undetected subclinical disease is always a concern in any
observational study, but it is less likely to have occurred in
our cohort because of the comprehensive physical examina-
tion and the clinical assessment completed for each partic-
ipant. Moreover, participants were healthy enough to
achieve at least 85% of age-predicted maximal heart rate
during the treadmill test. In addition, excluding deathsduring the first 3 years of follow-up did not alter the results
in the current study.
Conclusions
This study found that high levels of muscular strength are
associated with a lower risk for all-cause mortality in men
with diagnosed hypertension, and this is in addition to the
protective effect provided by CRF. Hypertensive men
should follow current physical activity guidelines and engage
in muscle-strengthening activities that involve major muscle
groups, not only to reduce resting blood pressure but also to
potentially reduce long-term mortality risk. Hypertensive
men can attain even greater reduction in mortality risk if
they maintain high levels of both muscular strength and
CRF.
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